B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma (B-NHL) is a type of cancer that originates in the B-cells of the lymphatic system, leading to the growth of tumors and affecting the body's ability to fight infections.
Aggressive B-cell Non-Hodgkin Lymphomas: REGN5837 and Odronextamab
We are studying the safety of a new treatment combination for adults with aggressive B-cell non-Hodgkin lymphomas. This trial aims to see how well these medications work together.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Département d’hémato-clinique et thérapie cellulaire
Canéjan, France
Hopital Saint Louis
Département d’hémato-oncologie
Quinze-Vingts, France
Institut Gustave Roussy
Département d’hématologie
Villejuif, France
Sponsor: Regeneron Pharmaceuticals Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.